CHICAGO--(BUSINESS WIRE)--Research presented at the American Heart Association Scientific Sessions 2006 validate the role of lipoprotein-associated phospholipase A2 (Lp-PLA2), a cardiovascular-specific inflammatory enzyme associated with unstable plaque that can lead to heart attack and stroke, in the identification of patients at risk for cardiovascular disease and the prevention of subsequent events.
